News
Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by ...
So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and ...
Privately-held US clinical-stage biotech Cellergy Pharma announced the appointment Christopher Cano as chief executive (CEO).
Investing in clinical-stage biotechnology always carries significant risks, and aTyr is no exception. The company reported a ...
2h
Global News - Inquirer.net on MSNWill China’s home-grown obesity drugs reshape global weight loss market?July, video editor Meng Meng, 38, has been injecting herself with a weekly weight loss drug, hoping it will finally help her ...
People who ate more typical home-cooked meals lost twice the weight of people eating ultraprocessed foods that met healthy ...
A few years have passed since the height of the COVID-19 pandemic, but but researchers estimate millions of people are still ...
Texas hates when people get high, but the state is on its way toward legalizing ibogaine, a potent, potentially fatal ...
A recent narrative review describes how to identify and manage pneumonia that does not respond to antibiotic treatment.
MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for the ...
ALKU, a leading specialty staffing firm, today announced that its President, Andrew Bull, has been appointed Chief Executive ...
6d
Stockhead on MSNMoneyTalks: Summit Biotech Fund’s three standout ASX healthcare stocksSummit Biotech Fund backs opportunities in the ASX healthcare space and sees upside in three particular names including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results